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INTRODUCTION
Hepatic Encephalopathy (HE), an extra-hepatic
complication of impaired liver function that may be
present in 50-70% of all liver cirrhosis patients, is
a neuron-psychiatric syndrome, which can develop in
acute or chronic liver disease.1,2 It remains a major
cause of morbidity and mortality in chronic liver
disease.
The clinical manifestations of HE range from subtle
abnormalities detectable only by psychometric testing
to deep coma. Formerly, those manifestations were
thought to be due to the false neuron transmitters.
However, recent evidences reveal that those are as
reflection of a low grade cerebral edema due to
astrocyte swelling which is aggravated by
precipitating factors.3,4 In this context, astrocyte plays
an important role as major site of ammonia
detoxification in HE.
The aim of treating these patients is to treat
the identifiable precipitating factors, which can lead to
recovery from an episode of HE. Additional measures
are applied to enhance recovery e.g. limiting the
generation or absorption of ammonia from the gut.
PATOPHYSIOLOGY
Depending on the appearance and the speed of
the development of the precipitating factors,
the magnitude of liver damage and the portal-systemic,
HE can be divided in two forms of manifestations:
porto- systemic encephalopathy and the HE with acute
liver failure.
The acute form of HE can rapidly progress to
full-blown syndrome, which does not respond to
treatment and has unfavorable prognosis. The chronic
form of HE is more common than the acute form,
occurring in up to 50-80% of liver cirrhosis patients.5
The symptoms of mental states gradation are shown
in table 1.
In the past studies of HE focused primarily on
the impaired neurotransmission observed in hyper-
ammonia. Evidence-based medicine showed that
disturbances of neurotransmission in HE seem to be
due to astrocytes swelling leading to astrocyte
dysfunction.
Under physiological metabolic conditions,
ammonia is present in the blood (normal peripheral blood
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NH3 = 30 mmol/liter), crosses the blood-brain barrier,
and enters the astrocytes, where it binds glutamate
synthetase to glutamate, giving rise to glutamine.
To maintain glutamine level within physiological level,
the excess is removed from the astrocytes through
specific transport system, since the blood-brain barrier
is impermeable to amino acids.
Hyper-ammonia in HE, whether it comes from
intestinal over production due to dietary protein
overload, obstipation, GI tract bleeding, tissue
bleeding, azotemia or extra intestinal caused by
catabolism (in septic condition, infections, surgical
intervention or fever), could lead to deleterious effect.
Excessive amount of ammonia reaches the astrocytes,
which in turn increasing the level of glutamine inside
the astrocytes, reaching beyond physiological high level
limit in these cells. Glutamine; just like ammonia, is
osmotically active. It causes more water enter
the astrocytes, and makes these cells swell.5
In acute HE, astrocytes swelling occurs rapidly and
develops into brain edema. Since it develops rapidly in
progressing liver failure with increasing blood
ammonia level, the brain cells do not have sufficient
time or capacity to overcome this osmolarity
disturbance.5
In chronic HE, on the other hand, brain edema is
rare. Since this form of HE develops insidiously, and
blood ammonia level increase slowly, the astrocytes
are initially able to compensate, at least in part for
osmotic effect of ammonia. Nevertheless, some
astrocytes swelling also develop.
Ammonia in HE also affects permeability of
the astrocytes membrane that is not more permeable
generally; rather, it seems that only affects specific
transport mechanism.5 It is supported by the fact that
steroids do not have any effect on cerebral edema in
HE-in contrast to stroke, where such edema regresses
rapidly by steroid administration.
Despite hyper ammonia is the cause in inducing
astrocytes swelling that lead to HE, there is no
correlation between blood ammonia concentration with
the degree of HE. Suspected HE must then be
confirmed by different diagnosis, and a search
undertaken for possible liver disease. Because
majority HE is induced by precipitating factors,
treatment is aimed to to these abnormalities.
There are three sources where ammonia comes
from: first, it comes from the large bowel. colonic flora
convert urea as protein metabolite into ammonia which
in normally converted back to urea by the liver.
The second source (less important) of ammonia comes
from converted glutamine by renal tubular and the last
ammonia comes from the catabolism of protein, urea
and DNA. Hyperammonia can be originated from
the increase of intestinal (due to dietary protein
overload, obstipation, GI bleeding, azotemia) and/or
elevated extra intestinal (catabolism due to septic,
infections, surgical intervention, fever.7 Ammonia is
metabolized in the liver and outside the liver (brain,
muscle and other tissue). In cirrhotic liver, this
capacity is reduced leading to increased burden of brain
(astrocytes) and other tissue to eliminate/metabolize
this substance.
The brain of cirrhotic patients with HE consistently
show a depletion of myo-inositol accompanied by
an increase in the ratio glutamine/glutamate signal,
which indicates astrocytes swelling as an early
pathogenetic event in HE.1 It was suggested that
the increase in brain water not merely results from
ammonia induced astroglial glutamine accumulation, but
also induced by other HE-relevant factors.
Diet of liver cirrhosis patients
Energy and protein balance can be obtained by
providing 30-40 kcal/kgBW/day and the amount of
Table 1. Mental state gradation of HE severity (West- Haven criteria) 6 
Hepatic Encephalopathy 
Grade Clinical Symptoms  
0 No overt symptoms; no pathological psychometric 
Minimal 
(sub clinical, latent) 
No overt symptoms; pathological psychometric 
I Disturbed sleep-wake rhythm, restless, irritability, euphoria, anxiety, aimless, shortened 
attention span, trivial lack of awareness, impaired performance of addition 
II 
Lethargy or apathy, overt personality changes, lassitude, minimal disorientation for time 
and space, memory weakness, yawning, impaired performance of subtraction. 
Inappropriate behavior  
III Somnolence to semi-stupor, conclusion, disturbed articulation responsive to verbal 
stimuli, gross disorientation 
 
Table 2. Principles of the treatment of HE.6 
Eliminating of precipitating factors 
- Stop GI bleeding, evacuation of blood from the GI tract, 
avoidance of to many blood transfusions 
- Avoidance of azotemia 
- Arterial hypotension and hypoxemia 
- Reduction of  diuretic therapy to an acceptable minimum 
- Stop dehydration, correction of water and electrolyte 
imbalance, avoidance of hypokalemia or excessive 
ascites paracenthesis 
- Strict avoidance of benzodiazepines, sedative or other 
psychoactive drugs 
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protein intake which will assure nitrogen balance in
most patients is around 1.2-1.3 g/kg BW/day.8
Cirrhosis patients utilize dietary protein very efficiently.
With increasing dietary protein, the increase in
nitrogen retention was 85% of the protein intake. This
utilization is similar to that of malnourished individuals
without any organ disease.8
In the past patients with liver disease were
instructed to limit their protein intake in their diet
because high protein ingestion was assumed to increase
ammonia production which induce HE. This approach
of cause aggravated the nutritional depletion that
typically already present in patients with chronic liver
disease whose prevalence as high as 65-90%,
depending on etiology of disease (alcoholic-non
alcoholic) and the severity of liver failure.9,10 Inadequate
protein intake can cause a negative nitrogen balance
and tissue catabolism that may aggravate HE by
 increasing the plasma and brain contents of aromatic
amino acids (phenylalanine, tyrosine, tryptophane).
These patients should therefore, consume normal
amount of protein in their diet, and only small group of
them with end stage liver disease cannot tolerate
normal diet. BCAA (valine, leucine, and isoleucine)
may be beneficial for some patients who are judge to
be protein intolerant.8 BCAA stimulates insulin
production and increase uptake sugar and amino acid.
It is also differently metabolized in the muscle not like
other amino acids, which are broken down in the liver.
All of the three BCAA have to be available at the same
time to ensure maximum utilization and should be taken
on empty stomach because they actively compete with
other amino acids for uptake and utilization.11
Boon L et al, found in rats that ingestion of liberal
amounts of dietary protein, promote urea cycle
enzymes and enable adequate protein metabolism.9
This phenomenon, even in small sample size, was also
demonstrated in patients with HE.12 They proved that
there was no different of plasma ammonia, bilirubin,
prothrombine activity, albumin level between group
patients who received low protein (30 cal/kgBW/day;
protein < 1.2 g/kg BW/day) with those who had
normal protein diet (30 cal/kgBW/day, protein
1.2 gram/kgBW/day). However, there was exacerbated
protein breakdown in the low protein group without
differences in protein synthesis. As the protein intake
in both group were equalized, there were no
differences in either protein synthesis or breakdown.
ESPEN 1997,13 recommended protein intake for
HE patients 0.5 g/kgBW/day in short time, and then
increase it to 1.0-1.5 g/kg/day with non protein energy
25-35 cal/kgBW/day. The ESPEN 2006,14
recommended energy intake of 35-40 cal/kgBW/day
and protein 1.2-1.5 g/kg BW/day for liver cirrhosis
patients and BCAA enriched formulae should be used
in patients with hepatic encephalopathy occurred
during enteral nutrition.
Condition in which “amino acid toxicity” occurs is
in GI bleeding in liver cirrhosis patients. Self-digestion
of blood will induce encephalopathy due to lack of
essential amino acid isoleucine in hemoglobin which
make it as a protein of biologically low value. The lack
of protein synthesis leads to elevate plasma amino
acids levels including leucine and valin e without
isoleucine. The high level of valin and leucine
stimulate BCAA dehydrogenase which in turn lead to
degradation of all BCAA including isoleucine; that will
aggravates amino acids imbalance further.15
To overcome the reducing capacity of the cirrhotic
liver to metabolize ammonia, it is thought to lower
ammonia level by (1) decreasing ammoniogenic
substrate and (2) lowering ammonia production.
Decreasing ammoniogenic substrate
In the past, by reducing of total protein intake only
for short time was presumed to be useful to improve
HE grade.13 Recently, this approach has been
challenged. The other method is by utilizing less
comagenic types of protein. Blood protein and meat
protein are more ammoniogenic and presumably more
comagenic than vegetable protein.
Vegetable protein is better tolerated by patients
susceptible to HE This beneficial effect may be due to
its higher content of fiber in vegetable protein than in
animal protein with an equal amount of nitrogen.
The fiber increases the transit time of food through
the intestine and lower the pH of colonic lumen as
a result of its fermentation by colonic bacteria.7,16
Lowering ammonia production
It is already known that ammonia is produced mainly
in the gut and extra intestinal from protein. Thus,
the quantity and the quality of protein as part of bolus
meal must be taken into consideration e.g. its
composition, digestibility, absorption of the amino
acids.17
Amino acid composition suitability of protein in
the meal is those, which are very gradually delivered
into the portal and subsequently into the systemic
circulation. This will give more time to the already
decreasing ability of cirrhotic liver cell to metabolize
ammonia produced. This composition depends on
(1) nutritional co-factors that promote protein
synthesis, decelerate the post prandrial appearance of
amino acids in the portal vein, diminish urea
synthesis, and improve nitrogen balance. Those
factors include adding carbohydrates to protein and
adding essential amino acids to the low value
protein, (2) the quality of protein itself. After
digestion, re-sorption, and re-synthesis process,
protein is slowly degraded and released as amino
acids into portal vein. In turn, this leads to better
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utilization of these amino acids in the liver or elsewhere
in the body and to low levels of urea production.
In addition, slow stomach emptying or slow digestion
of protein adds beneficial effect. Casein is a slow
protein partly because of its coagulation in
the stomach and subsequent slow passage and
digestion and (3) the labile protein pool: proteins that
temporarily accumulate after meal in the gut include in
this setting as enzymes synthesized in the process of
digestion and secreted into the gut, mucus, and
enterocytes in the gut lumen.
Application of those mentioned above in daily life,
it is recommended for cirrhotic patients (even healthy
individuals) to eat balance food with high quality
protein, combined with other nutrients including
macronutrient such as carbohydrates in frequent small
portions. When most of the protein is taken up during
one meal, the gut is unable to assimilate a large
proportion of it because the capacity of the labile
protein pool is exceeded.18 This will exceed the
capacity of the cirrhotic liver to metabolize as well.17
CONCLUSION
Hepatic Encephalopathy (HE) is an extra hepatic
complication of impaired liver function, manifested from
mild abnormality psychometric test to deep coma,
caused by astrocyte swelling. The swelling of
astrocytes is not merely caused by hyper-ammonia,
but many factors involved.
In addition to correct precipitating factors that
 induce HE, giving appropriate diet will mostly improve
the HE. It has been proven that providing diet to HE
patients equal with those normal people with calorie
intake 30-40/kgBW/day and protein intake
1.2-1.3 g/kgBW/day, showed more beneficial effects
than restricted protein diet as majority current diet
protocols.
It is recommended to eat balance food with high
quality protein combined with other macronutrients in
frequent small portions. Protein with less
ammoniogenic/comagenic effect e.g. vegetable
protein is more preferable. For those who show any
protein intolerant effects during treatment such as
worsen the degree of HE, it is recommended to change
to BCAA enriched diet.
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